W. Lerbs

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

Joachim Bischoff, Gϋnter von Minckwitz, Akin Atmaca et al. · British Journal of Cancer · 2006 · 68 citations · Full text

Medicine, Oncology, Pharmacology +14

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m<sup>2</sup> Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Salah‐Eddin Al‐Batran, H.G. Meerpohl, Gϋnter von Minckwitz et al. · Oncology · 2006 · 51 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials

S-E. Al-Batran, M Güntner, Claudia Pauligk et al. · British Journal of Cancer · 2010 · 35 citations · Full text

Medicine, Oncology, Pharmacology +16